EXTRAPHARM HUY

The annual accounts of EXTRAPHARM HUY for financial year 2025 show a net loss of 88% of the equity at the start of that year. The 2025 annual accounts show equity of €17,633 and a net result of -€124,683. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 13% of 5,017 sector peers (NACE 47, financial year 2025). The company has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.2% (low).